Your browser doesn't support javascript.
loading
Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolism.
Limperger, Verena; Torge, Antje; Kiesau, Bettina; Langer, Florian; Kenet, Gili; Mesters, Rolf; Juhl, David; Stoll, Monika; Shneyder, Maria; Kowalski, Dorothee; Bajorat, Tido; Rocke, Angela; Kuta, Piotr; Lasarow, Livia; Spengler, Dietmar; Junker, Ralf; Nowak-Göttl, Ulrike.
Afiliación
  • Limperger V; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Torge A; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Kiesau B; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Langer F; Department of Hematology & Oncology, Univ. Hospital Hamburg, Germany.
  • Kenet G; National Hemophilia Center, Institute of Thrombosis and Hemostasis, Sheba Medical Centre, Tel-Hashomer, Israel; The Amalia Biron Research Institute of Thrombosis & Hemostasis, Tel Aviv University, Israel.
  • Mesters R; Department of Medicine/Hematology & Oncology, Univ. Hospital Münster, Germany.
  • Juhl D; Institute of Transfusion Medicine, Univ. Hospital Kiel & Lübeck, Germany.
  • Stoll M; Institute of Human Genetics, Westfälische-Wilhelms-University, Münster, Germany; Cardiovascular Research Institute Maastricht, Maastricht University, the Netherlands.
  • Shneyder M; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Kowalski D; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Bajorat T; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Rocke A; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Kuta P; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Lasarow L; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Spengler D; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Junker R; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany.
  • Nowak-Göttl U; Institute of Clinical Chemistry, Univ. Hospital Kiel & Lübeck, Germany. Electronic address: leagottl@uksh.de.
Blood Cells Mol Dis ; 94: 102651, 2022 05.
Article en En | MEDLINE | ID: mdl-35051688
ABSTRACT

BACKGROUND:

To develop and validate a predictive model to determinate patients at increased risk to suffer from recurrence following a first provoked deep vein thrombosis (VTE).

METHODS:

Predictive variables, i.e. male sex [1 point], inherited thrombophilia (IT) status (none [0 points], single [1 point], combined variants [2 points]), blood group non-0, and age at first VTE onset were included into a risk assessment model, which was derived in 511 patients and then validated in 509 independent subjects.

RESULTS:

VTE recurrence risk score (maximum 4 points, range 0-3) was below two for patients scored as low-risk (LRS) and ≥2 for patients at high-risk (HRS). Within a median time of 3 years after withdrawal of anticoagulation (AC) recurrence rate in LRG (derivation) was 11.8% versus 26.0% in HRS (p < 0.001). In the validation cohort within 2.2 years the recurrence rate was 9.8% in LRS versus 30.1% in HRS (p < 0.001). In multivariable analysis adjusted for age at first VTE and blood group the recurrent risk in HRS was significantly increased compared with the LRS (derivation hazard/95% confidence interval 3.7/1.75-7.91; validation 4.7/2.24-9.81; combined 5.2/1.92-13.9). Model specificity (sensitivity) was 79.0% (52.0%) in the derivation cohort compared with 78.0% (43.0%) in the validation group. In conclusion, in the prediction model presented here the risk of VTE recurrence was associated with male gender and combined ITs. Based on the negative predictive value calculated the model may identify patients with a first provoked VTE not being at risk for recurrence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Trombofilia / Trombosis de la Vena / Tromboembolia Venosa Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Trombofilia / Trombosis de la Vena / Tromboembolia Venosa Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania